SOST and periodontitis: In animal experiments, an increase in sclerostin-positive osteocytes within alveolar bone was linked to a decrease in bone formation in a mouse model of periodontitis [55, 56]; in parallel, the administration of sclerostin- and DKK1-specific antibodies markedly improved alveolar bone volume and structure [57, 58].